From Wikipedia, the free encyclopedia
|(what is this?)|
- World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103" (PDF). WHO Drug Information.
- Another IL-6 Blocker in RA
- Genovese, MC (2014). "Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study". Ann Rheum Dis. doi:10.1136/annrheumdis-2013-204760. Retrieved 21 February 2016.
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|